NDC 51662-1567-01 - COSYNTROPIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1567
- Requested NDC
- 51662-1567-01
- Package NDCs from labels
- 51662-1567-1, 51662-1567-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-02-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| COSYNTROPIN - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1567-1 | COSYNTROPIN | 1 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1567 | COSYNTROPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 2 | Current NDC, Legacy NDC, 1 package rows | 20240224_c6cf2223-4a93-0b28-e053-2a95a90ade53.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Cortrosyn | CORTROSYN | Henry Schein, Inc. | 0c424fac-b114-41f6-aba8-cf710a34c26c | 2025-06-17 | Warnings, Adverse reactions | 72YY86EA29 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Cortrosyn | COSYNTROPIN | Amphastar Pharmaceuticals, Inc. | 746856e9-3930-4f6a-b8e6-a03845d6dd0b | 2025-01-30 | Warnings, Adverse reactions | 72YY86EA29 |
| Cortrosyn | COSYNTROPIN | Medical Purchasing Solutions, LLC | 15eaaab2-d656-7310-e063-6394a90ae59f | 2024-04-12 | Adverse reactions | 72YY86EA29 |
| COSYNTROPIN | COSYNTROPIN | HF Acquisition Co LLC, DBA HealthFirst | c6cf2223-4a93-0b28-e053-2a95a90ade53 | 2024-02-22 | Adverse reactions | ANDA202147 51662-1567-1 51662-1567 51662156701 120401a8-c1c7-581c-e063-6294a90a94f8 c6cf2223-4a93-0b28-e053-2a95a90ade53 72YY86EA29 |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| Cosyntropin | COSYNTROPIN | Sandoz Inc | 1342169c-e214-4f22-8363-1fd45b85d1e8 | 2024-01-10 | Warnings, Adverse reactions | ANDA202147 0781-3440 7e07a53d-7214-4471-859f-059d66318106 1342169c-e214-4f22-8363-1fd45b85d1e8 72YY86EA29 |
| Cosyntropin | COSYNTROPIN | Medical Purchasing Solutions, LLC | 09441f78-7350-0cb3-e063-6394a90a46ab | 2023-11-03 | Adverse reactions | ANDA202147 72YY86EA29 |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |